October 25, 2019
Reckitt Benckiser LLC won't have to pay attorney fees racked up by generic-drug makers it unsuccessfully sued on claims that they ripped off patents for its Mucinex respiratory relief drug, although a New Jersey federal judge on Friday said the decision on the fees was a "close call."
August 22, 2017
A pair of generic-drug makers that Reckitt Benckiser had accused of ripping off patents it holds for the respiratory relief drug Mucinex were let off the hook Tuesday by a New Jersey federal judge who was unconvinced by a Reckitt expert's testimony that the drugs' formulations were similar.
May 15, 2017
Reckitt Benckiser LLC on Monday brought its Mucinex patent infringement case against two generic pharmaceutical companies to trial, telling a New Jersey federal judge that it can prove that the alleged imposters consist of immediate- and extended-release elements that belie their makers' claims that they have only homogenous formulas for the respiratory relief drug.